Barclays Maintains Equal-Weight on Radian Group, Raises Price Target to $36
Barclays analyst Terry Ma maintains Radian Group (NYSE:RDN) with a Equal-Weight and raises the price target from $35 to $36.
Stocks · News reference
8-K filing — RADIAN GROUP INC (RDN)
Filed: 2026-08-06 AccNo: 0001193125-26-336793 Size: 3 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
FHFA Director Bill Pulte Says In X Post That Fannie Mae Will Follow Freddie Mac's Rule Allowing Loan Servicers To Contact Borrowers Who May Qualify To Cancel Private Mortgage Insurance
https://x.com/pulte/status/2099876969483567277
AIZ Rallies 32.9% in a Year: Time to Buy the Stock for Solid Returns?
Assurant (AIZ) has surged 32.9% over the past year, outperforming its industry. The company raised its 2026 Global Lifestyle adjusted EBITDA growth outlook to low double digits and Global Housing now expects modest earnings growth. With a Zacks Rank #2 (Buy) rating, attractive valuations, strong return on capital metrics, and analyst upgrades, the stock appears positioned for further gains with a 16.2% upside potential based on analyst price targets.
RDN's Underwriting Discipline Key to Navigating Softer Pricing
Radian Group (RDN) is navigating softer specialty insurance pricing following its February 2026 acquisition of Inigo, which significantly expanded its specialty insurance and reinsurance exposure. The company is prioritizing risk-adjusted profitability and selective capital deployment over premium growth to mitigate margin pressure. While RDN's underwriting discipline and analytics capabilities should help maintain profitability, the stock trades at a discount to peers with a forward P/B of 0.99X versus industry average of 2.67X, though analyst estimates have declined recently.